Skip to main content

Licensing

  • PDX, HDS fuse automation, data with verification tool

    FORT WORTH, Texas — Blending the power of one of the most widely used pharmacy automation systems with a massive database of prescribing physicians, two major pharmacy technology providers have unveiled a new partnership designed to give dispensing pharmacists immediate access to real-time prescriber data.


    Retail pharmacy technology provider PDX and Healthcare Data Solutions announced the alliance in November. The goal, according to both companies, is to link users of the PDX Pharmacy System with a real-time prescriber verification process.


  • Pharmacy systems providers link up to offer improved prescriber verification

    FORT WORTH, Texas — Integrated pharmacy systems provider PDX and Health Market Science, a leading source for health provider data and solutions, have teamed up to improve the accuracy and safety of the prescription verification process.

  • PTCB leader to serve as president of ICE

    WASHINGTON The head of an organization that accredits pharmacy technicians will serve as president of an international credentialing organization next year.

     

    The Pharmacy Technician Certification Board announced Thursday that executive director and CEO Melissa Murer Corrigan would serve as the 2011 president of the Institute for Credentialing Excellence and be installed at the ICE Annual Education Conference in Atlanta, which also took place Thursday. ICE provides educational, networking and advocacy resources for credentialing organizations.

     

  • Labopharm reviewing notification of Actavis' approval application for generic Oletpro

    LAVAL, Quebec — Generic drug maker Actavis has filed for approval of a generic version of an antidepressant made by Canada’s Labopharm, Labopharm said.

     

    The drug maker said it received a notification stating that Actavis had applied to the Food and Drug Administration for approval of a generic version of Oletpro (trazodone hydrochloride) extended-release tablets in the 150-mg and 300-mg strengths.

     

     

  • Arbor receives $35 million in financing

    ATLANTA Drug maker Arbor Pharmaceuticals has obtained nearly $35 million in financing, the company said Thursday.

     

    Arbor said the $34.8 million included a $17.5 million investment in the form of Series B Preferred Stock, mostly from Signet Healthcare Partners, while the rest was in the form of a loan provided by investors, as well as portions of the loan and investment from existing shareholders. The company markets drugs for such indications as nasal hygiene and dermatitis.

     

     

  • Eden, Crucell ink manufacturing agreement

    RESEARCH TRIANGLE PARK, N.C. Watson Pharmaceuticals biotech subsidiary Eden Biodesign has signed a manufacturing agreement with Dutch biotech company Crucell that will give Watson access to Crucell’s cell line technology, the two companies announced Wednesday.

     

    Under the agreement, Eden will provide process development and current good manufacturing practice services using Crucell’s PER.C6 technology to licensees using the technology to develop vaccines and gene therapies.

     

     

  • PDX, Healthcare Data Solutions partner to provide prescriber verification process to PDX users

    FORT WORTH, Texas Retail pharmacy technology provider PDX has partnered with Healthcare Data Solutions to provide users of the PDX Pharmacy System with access to a real-time prescriber verification process.

    The companies said the integration of the PDX Pharmacy System and the HDS ProscriberPRO database would allow immediate verification of prescribers and associated profiles when a prescriber is added or before a prescription is filled, with access provided over a secure, Web-based service.

X
This ad will auto-close in 10 seconds